The minimal inhibitory concentrations of a series of antimicrobial agents for human oral organisms were determined under anaerobic growth conditions by an agar dilution assay. With the exception of black-pigmented Bacteroides spp., minimal inhibitory concentrations for oral isolates were similar to those for nonoral isolates of organisms of the same or closely related species.
Bacteria indigenous to the human oral cavity can cause various clinical infections. Streptococcus mutans and Lactobacillus and Actinomyces spp. are associated with supragingival plaque leading to dental caries (11) and gingivitis (22) . Fusobacterium nucleatum, Eikenella corrodens, and corroding Bacteroides spp., Capnocytophaga spp., and anaerobic vibrios (22) , as well as Bacteroides gingivalis, Bacteroides melaninogenicus subsp. intermedius, and Actinobacillus actinomycetemcomitans (26) , are associated with periodontitis. Many orofacial abscesses are mixed anaerobic infections. B. melaninogenicus, Bacteroides oralis, Bacteroides corrodens, streptococci (7) , and Actinomyces israelii (31) have been isolated from periapical abscesses. A. israelii and A. actinomycetemcomitans are found in actinomycosis (19, 24) . B. melaninogenicus (3, 7) , B. oralis (7), B. corrodens (7), Campylobacter spp., (7), F. nucleatum (3, 7) , Veillonella parvula (7) , and streptococci (3, 7) can give rise to infections of the perimandibular fascial spaces. Various Bacteroides and Campylobacter spp., V. parvula, and Actinomyces spp. are frequent isolates of mandibular osteomyelitis (7) . Organisms also can seed from the oral cavity to other parts of the body and cause clinical infections. Systemic antibiotic therapy is useful in the treatment of infections caused by oral bacteria (2, 4, 10, 12, 15, 24) . Few data exist, however, on the antibiotic susceptibilities of oral facultative and anaerobic organisms. Also, it is unclear as to whether oral isolates differ from non-oral isolates in their antimicrobial susceptibilities. In this study we tested the susceptibilities of isolates of the major bacterial species from the human oral cavity to several antimicrobial agents.
Bacteria studied were freshly isolated as previously described (28) from periodontitis patients. Isolated strains were characterized by established procedures (8, 16, 34 Some strains ofB. gingivalis, B. melaninogenicus subsp. melaninogenicus, and B. melaninogenicus subsp. intermedius grew poorly on the agar medium and several other broth and agar media. The susceptibility testing of these strains was performed by an accepted broth macrodilution technique (18) , except the tests were done in brain heart infusion broth (BBL Microbiology Systems, Cockeysville, Md.) with added hemin (5 ,ug/ml) and vitamin K (0.5 ,ug/ml) and incubation was carried out for 4 days, as for the agar dilution tests. Some Bacteroides strains and the E. coli and S. aureus control strains were tested by both agar dilution and broth dilution. The two methods gave similar MICs; therefore, the broth dilution MICs for strains for which MICs could be obtained only by this method were combined with the agar dilution MICs for the other strains.
The lowest concentrations required to inhibit 50 and 90%o of the strains are shown in Tables 1  and 2 .
The results are generally similar to those previously published for non-oral clinical isolates of these species when tested anaerobically by agar dilution (1, 5, 6, 13-15, 17, 20, 25, 29, 32, 33) . Each of these studies contained one or more of the drug organism combinations tested in the presept study.
The MICs reported here for oral B. melaninogenicus, however, were lower than those reported for non-oral B. melaninogenicus strains when tetracycline (1, 5, 6, 14, 20, 21) , minocycline (6, 29, 32), penicillin (1, 5, 14, 20, 21, 29) , and carbenicillin (1, 14, 29, 32) were considered. Available MICs for oral B. melaninogenicus, i.e., those of tetracycline (23, 35) and penicillin (23, 36) , were also lower than those reported for non-oral strains. For clindamycin, erythromycin, and metronidazole, the present MICs agree with those previously published for oral (23, 36) and non-oral ( 1, 14, 20, 21, 29, 32 ) strains.
The MICs of spiramycin or clindamycin obtained in this study for A. actinomycetemcomitans are somewhat higher than those reported for non-oral strains (15) but agree with earlier results on periodontal A. actinomycetemcomitans (27) . MICs of metronidazole for Capnocytophaga spp. agree with those of some previotis reports (9, 23) but are lower than those reported by Sutter et al. (33) . Erythromycin MICs for oral S. mutans in the present study were higher than those found for S. mutans from endocarditis patients (2) but were also higher than those reported for oral streptococci (36) . MICs for oral S. mutans were not different from those of tetracycline (2) or penicillin (2, 4) for S. mutans isolates from endocarditis patients.
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